Citius Oncology Inc.
CTOR - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$53.88M
Close$
$0.00
99.7% downside
Current Fair Value
99.7% downsideOvervalued by 99.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $53.88 Million |
|---|---|
| Enterprise Value | $47.53 Million |
| Earnings per Share | $-0.34 |
| Beta | 3.4 |
| Outstanding Shares | 107,890,452 |
Return
| Return on Equity | -114.06% |
|---|---|
| Return on Assets | -41.09% |
| Return on Invested Capital | -88.60% |
Valuation & Multiples
| P/E Ratio | -1.21 |
|---|---|
| PEG | -1.83 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 6.69 |
| Enterprise Value to EBIT | -1.01 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.07
Consensus analyst estimateRevenue Estimate
$2.50 M
Consensus analyst estimateNext Earnings Call
Expected Date
December 17, 2026
EPS Estimate
$-0.07
Consensus analyst estimateRevenue Estimate
$3.29 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 13.11%▼ 1.13% |
|---|---|
| Total Invested | $9.20M▲ 4.15% |
| Investors Holding | 20▲ 7.00% |